Menu
Search
|

Menu

Close
X

RTI Surgical Inc RTIX.OQ (NASDAQ Stock Exchange Global Select Market)

4.48 USD
-0.02 (-0.44%)
As of 3:59 PM EST
chart
Previous Close 4.50
Open 4.54
Volume 28,232
3m Avg Volume 26,938
Today’s High 4.58
Today’s Low 4.45
52 Week High 5.05
52 Week Low 3.92
Shares Outstanding (mil) 63.46
Market Capitalization (mil) 285.58
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY18
210
FY17
280
FY16
273
FY15
282
EPS (USD)
FY18
-0.095
FY17
0.024
FY16
-0.307
FY15
0.198
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
28.86
Price to Sales (TTM)
vs sector
1.02
23.49
Price to Book (MRQ)
vs sector
1.55
3.93
Price to Cash Flow (TTM)
vs sector
116.18
20.30
Total Debt to Equity (MRQ)
vs sector
19.85
15.17
LT Debt to Equity (MRQ)
vs sector
19.85
11.36
Return on Investment (TTM)
vs sector
-2.91
12.65
Return on Equity (TTM)
vs sector
-6.51
14.38

EXECUTIVE LEADERSHIP

Curtis Selquist
Chairman of the Board, Since 2016
Salary: --
Bonus: --
Camille Farhat
Chief Executive Officer, Since 2017
Salary: --
Bonus: --
Peter Gearen
Vice Chairman of the Board, Since 2016
Salary: --
Bonus: --
Jonathon Singer
Chief Financial Officer, Chief Administrative Officer, Director, Since 2017
Salary: --
Bonus: --
Roger Rose
Executive Vice President - Tissue-Based Implants, President - RTI Donor Services, Since 2014
Salary: $330,016.00
Bonus: $89,104.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

11621 Research Cir
ALACHUA   FL   32615-6825

Phone: +1386.4188888

RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company's business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.

SPONSORED STORIES